Kyverna Therapeutics (KYTX) Profit After Tax (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Profit After Tax of -$39.9 million for Q1 2026, down 5.61% on a QoQ basis from -$37.8 million in Q4 2025, and up 10.77% year-over-year from -$36.0 million in Q1 2025.
Kyverna Therapeutics (KYTX) Profit After Tax (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Profit After Tax history runs 4 years deep, the most recent figure standing at -$39.9 million for Q1 2026.
- Quarterly Profit After Tax rose 10.77% year-over-year to -$39.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$156.6 million (down 7.62% YoY) and the FY2025 annual result came in at -$161.3 million, down 26.51% from the prior year.
- Profit After Tax was -$39.9 million for Q1 2026 at Kyverna Therapeutics, down from -$37.8 million in the prior quarter.
- Across five years, Profit After Tax topped out at $5000.0 in Q3 2023 and bottomed at -$60.4 million in Q4 2023.
- A 4-year average of -$31.8 million and a median of -$36.8 million in 2025 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 37.64% in 2024, while the deepest fall reached 686140.0% in 2024.
- Kyverna Therapeutics' Profit After Tax stood at -$60.4 million in 2023, then soared by 37.64% to -$37.7 million in 2024, then fell by 0.37% to -$37.8 million in 2025, then declined by 5.61% to -$39.9 million in 2026.
- Business Quant data shows KYTX's Profit After Tax at -$39.9 million in Q1 2026, -$37.8 million in Q4 2025, and -$36.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Kyverna Therapeutics | 447.52 Mn | 447.52 Mn | - | -39.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.92 Mn |
| Dec 31, 2025 | -37.80 Mn |
| Sep 30, 2025 | -36.79 Mn |
| Jun 30, 2025 | -42.08 Mn |
| Mar 31, 2025 | -44.74 Mn |
| Dec 31, 2024 | -37.66 Mn |
| Sep 30, 2024 | -34.30 Mn |
| Jun 30, 2024 | -28.80 Mn |
| Mar 31, 2024 | -26.69 Mn |
| Dec 31, 2023 | -60.40 Mn |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | -13.09 Mn |
| Mar 31, 2023 | -11.14 Mn |